For Immediate Release 2 May 2008

The Medical House PLC

Important Regulatory Milestone

The Medical House PLC (“TMH”)(AIM:MLH) the drug delivery specialist, announced on 7 December 2006 that it had signed a development, licensing and supply agreement with a global pharmaceutical partner relating to TMH technology.

TMH now announces that its global pharmaceutical partner has received regulatory approval in one of the principal territories to which the agreement relates for a drug, a different formulation of which is in development for use with TMH’s technology. The new formulation and its combination with the TMH device remain subject to regulatory approvals.

Ian Townsend, Chairman, The Medical House PLC, said:
“This is another significant milestone for The Medical House, and it further endorses our commitment to, and confidence in, our project with this partner. This approval enhances the certainty of achieving our business objectives and we look forward to reporting future progress for our drug delivery division in due course”.

-Ends-

For further information:
The Medical House PLC tel: 0114 261 9011
Ian Townsend, Chairman www.themedicalhouse.com
Bryan Bodek, Deputy Chairman.
David Urquhart, Managing Director

Buchanan Communications tel: 020 7466 5000
Tim Anderson / Rebecca Skye Dietrich

NomuraCode SecuritiesRichard Potts tel: 020 7776 1200